It is estimated that 2-3 million people in the United States have a congenital heart defect (CHD), and 30%-50% of those have kidney disease. Learn more about the unique needs, potential complications, and treatment considerations for patients with CHD requiring vascular access.

Continuing Education Instructions and Disclosure Information:

Contact hours available until 8/31/2022.

Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.

Faculty, Planners, and Speakers Conflict of Interest Disclosure:

Planning Committee Disclosures:
• Marijo Johnson – Employee, Fresenius Medical Care

There are no other disclosures to declare.

Commercial Support and Sponsorship:
No commercial support or sponsorship declared.

Accreditation Statement:
American Nephrology Nurses Association (ANNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP17499.

ANNA urges participants to be aware of the CNE requirements for relicensure in the states in which they hold a license.

Learning Outcome:
After completing this learning activity, the learner will review issues related to caring for patients with congenital heart defects who require dialysis.